Cardiac arrest due to oral potassium administration.
Cardiac arrest developed in two patients after the administration of oral potassium. Neither patient had renal insufficiency, but both had underlying heart disease. In one patient fatal ventricular fibrillation developed 4 days after he received an aortic valve replacement for aortic stenosis and while he was receiving oral potassium supplements. The serum potassium level before cardiac arrest was 8.1 meq. The second patient had angina and was given 40 meq of potassium orally 15 minutes after an exercise test which produced chest pain and S-T segment depression. One hour later, ventricular fibrillation developed. Resuscitation was successful. Both patients had electrocardiographic evidence of hyperkalemia. Oral administration of potassium may produce severe cardiac toxicity in patients with heart disease even when renal function is clinically normal.
D000284:Administration, Oral; D000787:Angina Pectoris / Q000188:drug therapy; D001024:Aortic Valve Stenosis / Q000188:drug therapy; D004562:Electrocardiography; D006323:Heart Arrest / Q000139:chemically induced* / Q000503:physiopathology / Q000628:therapy; D006350:Heart Valve Prosthesis; D006801:Humans; D006947:Hyperkalemia / Q000209:etiology*; D007668:Kidney / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012151:Resuscitation; D014693:Ventricular Fibrillation / Q000139:chemically induced
D011188:Potassium